A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples